Metformin may lower risk of prostate cancer death
Metformin, a widely used diabetes drug, may reduce the risk of dying from prostate cancer, according to new research. A study of nearly 4000 diabetic men found that those taking metformin when diagnosed with prostate cancer were less likely to die of the cancer or other causes compared to men using other diabetes drugs. “We demonstrated that metformin is associated with improved survival among diabetic patients with prostate cancer,” said Researcher.
Tableware can be dangerous
Melamine, a chemical that sickened and killed babies when it tainted baby formula can also leach off tableware and into food, according to a Taiwan study. The researchers in JAMA Internal Medicine warned that their findings don’t prove that melamine is harmful to people in the amounts detected when study participants ate hot soup from melamine bowls. Large doses of melamine, which is used in some types of fertilizer and in resin used to make tableware, killed six babies in China and sent thousands more to hospital with kidney damage in 2008. In high enough quantities, melamine can cause kidney stones and other kidney problems in adults. The researcher of Medical University in Taiwan found that melamine tableware may release large amounts of melamine when used to serve high-temperature foods.
Anyone who has a choice might as well avoid buying tableware made with melamine, because it does interact with some acidic foods in the microwave.
Weight loss may help oppose diabetes
Overweight people with pre-diseases can reduce their risk of developing type-2 diabetes by losing a significant amount of weight, according to new research.
The study found that those who lost 10 percent or more of the body weight had an 85 percent lower risk of developing diabetes within three years, while those who lost 5 percent to 7 percent of their body weight had a 54 percent lower risk.
